← All trials
NCT04292314
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2019
- Primary completion
- Oct 31, 2020
- Completion date
- Nov 30, 2020
- First posted
- Mar 3, 2020
- Last posted
- Mar 3, 2020
- Enrollment
- 500
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Beni Suef UniversityLead sponsor
- University of ArizonaCollaborator
- University of ArizonaStudy director
- Beni Suef UniversityCollaborator
- Beni Suef UniversityOverall official - principal investigator
- Beni Suef UniversityReponsible party - principal investigator
- Beni Suef UniversityStudy director
- Beni Suef UniversityStudy director
- Beni Suef UniversityStudy director
- Beni Suef UniversityStudy director
- Maternity and Children Hospital, MakkahCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.